Rare diseases
Investigational molecules
Locations
Back to Czechia53 clinical trials in Brandys Nad Labem, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
CzechiaStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
CzechiaA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
CzechiaStudy of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood
CzechiaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
CzechiaStudy on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
CzechiaPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
CzechiaKAI-9531 in Adults With Obesity or Overweight and Diabetes
CzechiaEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
CzechiaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
CzechiaStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
CzechiaStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Research focusing on chronic respiratory conditions, particularly investigating new treatments for COPD and asthma. Studies evaluate innovative therapies aimed at improving lung function and reducing disease exacerbations.
Multiple trials exploring combination therapies and novel compounds for better disease control.
Comprehensive research into heart disease prevention and treatment, including studies on heart failure, atrial fibrillation, and atherosclerotic cardiovascular disease.
Investigation of innovative medications targeting various aspects of cardiovascular health.
Studies examining treatments for Type 2 diabetes and related metabolic conditions, with a focus on cardiovascular outcomes and weight management.
Evaluation of new therapeutic approaches combining multiple treatment mechanisms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
